KEPEMRY Trademark

Trademark Overview

On Monday, July 19, 2021, a trademark application was filed for KEPEMRY with the United States Patent and Trademark Office. The USPTO has given the KEPEMRY trademark a serial number of 90835567. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, February 18, 2025. This trademark is owned by Eli Lilly and Company. The KEPEMRY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of Alzheimer's disease
kepemry

General Information

Serial Number90835567
Word MarkKEPEMRY
Filing DateMonday, July 19, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparation for the treatment of Alzheimer's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 8, 2022ASSIGNED TO EXAMINER
Wednesday, March 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 23, 2022SOU EXTENSION 1 FILED
Wednesday, November 23, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 15, 2023SOU EXTENSION 2 FILED
Monday, May 15, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 3 FILED
Monday, November 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024SOU EXTENSION 4 FILED
Thursday, May 16, 2024SOU EXTENSION 4 GRANTED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 18, 2025SOU EXTENSION 5 GRANTED
Tuesday, February 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2024SOU EXTENSION 5 FILED

Related Keywords

kepemry pharmaceutical alzheimer disease treatment preparation preparations namely